Subsequent screening of RECQL in 439 familial breast cancer patients (who had tested negative for BRCA1 and BRCA2 mutations) found nine patients with putative pathogenic mutations (three nonsense, one splice site and five missense mutations predicted to be pathogenic) giving an overall frequency of 2.0% (0.9% if missense variants are excluded). Here, BRCA1 is linked to breast cancer.